Filing Details

Accession Number:
0001209191-22-031363
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-05-23 16:55:38
Reporting Period:
2022-05-19
Accepted Time:
2022-05-23 16:55:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1802768 Royalty Pharma Plc RPRX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1016835 B Rory Riggs C/O Royalty Pharma Plc
110 E. 59Th Street
New York NY 10022
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Ordinary Shares Disposition 2022-05-19 26,304 $40.09 575,408 No 4 S Direct
Class A Ordinary Shares Disposition 2022-05-20 123,696 $39.28 451,712 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Class A Ordinary Shares 85,187 Indirect By New Ventures III LLC
Class A Ordinary Shares 15,000 Indirect By Spouse
Footnotes
  1. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.29 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  2. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.00 to $40.04 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.